Article
Published 18 Sep 2025
Mintz IRA Update — PhRMA's 2025 Policy Agenda And The Industry's Crossroads With The IRA And Drug Pricing Reform
Mintz
Your search returned 13,169 results
Refine Your Search
Search Results
- Relevance
- Newest
- Oldest
Article
Published 18 Sep 2025
Mintz IRA Update — 340B Roundup
Mintz
Article
Published 18 Sep 2025
FDA's Direct-To-Consumer Advertising "Crackdown": Impacts To Brands, Agencies And Influencers
Loeb & Loeb LLP
Article
Published 18 Sep 2025
Medical Wearables Under The Microscope: U.S. Regulatory, Data Privacy And Cybersecurity Perspectives
A&O Shearman
Article
Published 18 Sep 2025
Drug And Medical Device Regulation Under The Trump Administration
A&O Shearman
Article
Published 17 Sep 2025
California's Private Equity Bills Head To Gov. Newsom For Round 2: Are They Still Redundant?
Holland & Knight
Article
Published 17 Sep 2025
Recent Federal Developments For September 2025
Bergeson & Campbell
Article
Published 17 Sep 2025
MAHA Commission Report Details Federal Response To Childhood Chronic Disease
Holland & Knight
Article
Published 17 Sep 2025
NIH Prepares To Launch AI Initiative Transforming Medical Imaging Data Analysis And Advancing Personalized Medicine
Foley & Lardner
Article
Published 17 Sep 2025
Mintz IRA Update — 340B Roundup: Senate HELP Committee's Long-Awaited 340B Report Highlights Ongoing Problems But Provides Few Solutions
Mintz
Article
Published 17 Sep 2025
340B Roundup: CMS Proposes Steeper OPPS Clawbacks, Launches Drug Cost Survey With Public Comment
Mintz
Article
Published 17 Sep 2025
Mintz IRA Update — Redesigning Part D For CY 2026
Mintz
Article
Published 17 Sep 2025
Mintz IRA Update — Under Pressure: The Trump Administration's Drug Pricing Executive Orders
Mintz
Article
Published 17 Sep 2025
Make Our Children Healthy Again Strategy Report: Food And Nutrition Recommendations
Manatt, Phelps & Phillips LLP
Article
Published 17 Sep 2025
Monthly Federal Developments Memorandum
Bergeson & Campbell
Article
Published 17 Sep 2025
Enforcement Efforts In The United States To Prohibit Entry And Sales Of E-Cigarette Products
Buchanan Ingersoll & Rooney PC
Article
Published 17 Sep 2025
PhRMA's 2025 Policy Agenda And The Industry's Crossroads With The IRA And Drug Pricing Reform
Mintz
Article
Published 17 Sep 2025
Mintz IRA Update — IRA Medicare Drug Price Negotiation Program Updates For Q3 2025
Mintz
Article
Published 16 Sep 2025
Mintz IRA Update — 340B Roundup: HRSA Launches 340B Rebate Model Pilot Program Amid Ongoing Legal And Regulatory Shifts
Mintz
Article
Published 16 Sep 2025
Mintz IRA Update — 340B Roundup: States And Manufacturers Continue To Battle Over 340B Contract Pharmacies
Mintz